Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pfisterer from Basel. Audio Medica talked with him.
[audio:https://www.audiomedica.com/podcasting/14.Matt_Pfisterer-Drug-eluting_stents_may_confer_so_little_additional_benefit_to_low_risk_patients.mp3]
Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey 28 May, 2020 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 14 Nov, 2006 Hypertension: Pressure Different at the Centre 16 Nov, 2005 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014